934493-76-2,MFCD20276656
Catalog No.:AA00GU3J

934493-76-2 | N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98+%
in stock  
$16.00   $12.00
- +
2mg
98+%
in stock  
$28.00   $19.00
- +
5mg
98+%
in stock  
$40.00   $28.00
- +
25mg
98%(HPLC)
in stock  
$129.00   $90.00
- +
100mg
98%(HPLC)
in stock  
$335.00   $235.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GU3J
Chemical Name:
N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
CAS Number:
934493-76-2
Molecular Formula:
C13H14N6O
Molecular Weight:
270.2899
MDL Number:
MFCD20276656
SMILES:
CCn1c(=O)c(cc2c1nc(N)nc2C)c1n[nH]cc1
Properties
Computed Properties
 
Complexity:
425  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.5  

Literature

Title: Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.

Journal: Toxicology in vitro : an international journal published in association with BIBRA 20180201

Title: Garcia-Echeverria C, et al. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene. 2008 Sep 18;27(41):5511-26.

Title: Yu P, et al. Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway. Mol Cancer Ther. 2014 May;13(5):1078-91.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 934493-76-2
Tags:934493-76-2 Molecular Formula|934493-76-2 MDL|934493-76-2 SMILES|934493-76-2 N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
Catalog No.: AA00GU3J
934493-76-2,MFCD20276656
934493-76-2 | N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
Pack Size: 1mg
Purity: 98+%
in stock
$16.00 $12.00
Pack Size: 2mg
Purity: 98+%
in stock
$28.00 $19.00
Pack Size: 5mg
Purity: 98+%
in stock
$40.00 $28.00
Pack Size: 25mg
Purity: 98%(HPLC)
in stock
$129.00 $90.00
Pack Size: 100mg
Purity: 98%(HPLC)
in stock
$335.00 $235.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GU3J
Chemical Name: N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
CAS Number: 934493-76-2
Molecular Formula: C13H14N6O
Molecular Weight: 270.2899
MDL Number: MFCD20276656
SMILES: CCn1c(=O)c(cc2c1nc(N)nc2C)c1n[nH]cc1
Properties
Complexity: 425  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 20  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.5  
Literature fold

Title: Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.

Journal: Toxicology in vitro : an international journal published in association with BIBRA20180201

Title: Garcia-Echeverria C, et al. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene. 2008 Sep 18;27(41):5511-26.

Title: Yu P, et al. Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway. Mol Cancer Ther. 2014 May;13(5):1078-91.

Building Blocks More >
89151-73-5
89151-73-5
5-Amino-3-tert-butylisothiazole
AA00GU7R | MFCD17926249
885531-23-7
885531-23-7
2-AZEPAN-1-YL-5-(MORPHOLIN-4-YLSULFONYL)ANILINE
AA00GUBF | MFCD08444217
89850-92-0
89850-92-0
1,2-Dimethylpiperidin-4-amine
AA00GUEW | MFCD12024734
882670-92-0
882670-92-0
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-amine
AA00GUNC | MFCD11521589
931-07-7
931-07-7
4-Nitro-isothiazole
AA00GUWV | MFCD01716903
937648-03-8
937648-03-8
1-(1-Ethylpiperidin-3-yl)-N-methylmethanamine
AA00GVAY | MFCD08572188
900717-84-2
900717-84-2
[2-(1H-Imidazol-1-yl)propyl]amine hydrochloride
AA00GVFP | MFCD06446928
90923-75-4
90923-75-4
1-Methyl-1H-indole-5-carbaldehyde
AA00GVJT | MFCD08271908
91658-79-6
91658-79-6
3-(2-aminophenyl)quinoxalin-2(1H)-one
AA00GVOT | MFCD00023914
938458-59-4
938458-59-4
(2-Chlorophenyl)[2-(methoxymethoxy)phenyl]methanone
AA00GVSW | MFCD09055156
Submit
© 2017 AA BLOCKS, INC. All rights reserved.